Company code: Shan Dong Kexing Bioproducts Co.Ltd(688136) company abbreviation: Shan Dong Kexing Bioproducts Co.Ltd(688136) Shan Dong Kexing Bioproducts Co.Ltd(688136)
Annual report for 2021
Important tips
1、 The board of directors, board of supervisors, directors, supervisors and senior managers of the company guarantee the authenticity, accuracy and integrity of the contents of the annual report, and there are no false records, misleading statements or major omissions, and bear individual and joint legal liabilities. 2、 Unprofitable and unprofitable when the company is listed □ yes √ no III. tips on major risks
The company has described in detail the possible risks in the business process in this report. Please refer to “IV. risk factors” in “section III Management Discussion and analysis” of this report. 4、 All directors of the company attended the board meeting. 5、 Dahua Certified Public Accountants (special general partnership) issued a standard unqualified audit report for the company. 6、 Deng Xueqin, the person in charge of the company, Wang Xiaoqin, the person in charge of accounting, and Lu Haifeng, the person in charge of the accounting organization (the person in charge of Accounting), declare that they guarantee the authenticity, accuracy and completeness of the financial report in the annual report. 7、 The profit distribution plan or the plan of converting accumulation fund into share capital in the reporting period adopted by the resolution of the board of directors
Audited by Dahua Certified Public Accountants (special general partnership), in 2021, the company realized a net profit of 9646391426 yuan attributable to the owner of the parent company, of which the parent company realized a net profit of 6893013255 yuan. After withdrawing the legal surplus reserve of 689301326 yuan according to 10% of the parent company’s net profit, the actual distributable profit in 2021 was 6203711929 yuan and the cumulative distributable profit was 16277571979 yuan.
Profit distribution plan for 2021: the company plans to distribute cash dividends of 1 yuan (including tax) to all shareholders for every 10 shares based on the total share capital registered on the date of equity distribution. The above profit distribution plan has been deliberated and approved at the 32nd meeting of the first board of directors of the company and needs to be submitted to the general meeting of shareholders for deliberation and approval before implementation. 8、 Whether there are important matters such as special arrangements for corporate governance □ applicable √ not applicable IX. risk statement of forward-looking statements √ applicable □ not applicable
The future plans, development strategies and other forward-looking descriptions involved in this report do not constitute the company’s substantive commitment to investors. Please pay attention to investment risks.
10、 Whether there is any non operational occupation of funds by the controlling shareholders and their related parties no Xi. Whether there is any external guarantee in violation of the specified decision-making procedures no XII. Whether more than half of the directors cannot guarantee the authenticity, accuracy and completeness of the annual report disclosed by the company no XIII. Others □ applicable √ not applicable
catalogue
Section 1 interpretation Section 2 company profile and main financial indicators Section III Management Discussion and Analysis Section IV corporate governance Section V environment, social responsibility and other corporate governance 67 section VI important matters 75 Section VII changes in shares and shareholders 99 Section VIII preferred shares Section IX corporate bonds 108 section x financial report one hundred and nine
Financial statements containing the signatures and seals of the person in charge of the company, the person in charge of accounting work and the person in charge of accounting organization (the person in charge of the catalogue of documents for future reference).
The original of the audit report with the seal of the accounting firm and the signature and seal of the certified public accountant
Originals of all company documents and announcements publicly disclosed during the reporting period.
Section I interpretation
1、 Interpretation in this report, unless the context otherwise requires, the following words have the following meanings: Interpretation of common words
The company, the company and Shan Dong Kexing Bioproducts Co.Ltd(688136) refer to Shan Dong Kexing Bioproducts Co.Ltd(688136)
Shenzhen Tong’an / Tong’an pharmaceutical refers to Shenzhen Tong’an Pharmaceutical Co., Ltd., a wholly-owned subsidiary of the company
Shenzhen Kexing / Kexing pharmaceutical refers to Shenzhen Kexing Pharmaceutical Co., Ltd., a wholly-owned subsidiary of the company
Kexing Co., Ltd. refers to Shandong Kexing Biological Products Co., Ltd., the predecessor of the company
Keyi holding refers to Shenzhen Keyi pharmaceutical Holding Co., Ltd., the controlling shareholder of the company
Zhengzhong investment group refers to Zhengzhong Investment Group Co., Ltd., the indirect controlling shareholder of the company
Zhengzhong Industrial Holdings refers to Zhengzhong Industrial Holdings Group Co., Ltd., the company’s former controlling shareholder
Zhengzhong industrial control refers to Zhengzhong Industrial Holding Group Co., Ltd. and its subsidiaries
Shenzhen Hengjian refers to Shenzhen Hengjian enterprise management partnership (limited partnership), the sponsor shareholder of the company
Shenzhen yuzao enterprise management partnership (limited partnership). Shenzhen yuzao refers to the sponsor shareholder of the company, which was changed to Qingdao yuzao enterprise management partnership (limited partnership) on December 28, 2021
Changjiang fortune – Shan Dong Kexing Bioproducts Co.Ltd(688136) employee strategy refers to Changjiang fortune asset management – Bank Of Nanjing Co.Ltd(601009) – Changjiang fortune – Kexing system placement collective asset management plan, employee strategy placement collective asset management plan
China Securities Co.Ltd(601066) securities, recommendation institution and guarantee index China Securities Co.Ltd(601066)
Recommender
Certified public accountants, Dahua certified public accountants refer to Dahua Certified Public Accountants (special general partnership)
CSRC refers to the China Securities Regulatory Commission
Shanghai stock exchange refers to Shanghai Stock Exchange
Company Law refers to the company law of the people’s Republic of China
Securities Law refers to the securities law of the people’s Republic of China
The articles of association refers to the Shan Dong Kexing Bioproducts Co.Ltd(688136) articles of association
RMB / 10000 yuan / 100 million yuan refers to RMB / 10000 yuan / 100 million yuan
EUA means emergency authorized use
CGMP refers to the current good manufacturing practice
Ind refers to new drug clinical research application
Section II Company Profile and main financial indicators
1、 Basic information of the company
Chinese name of the company Shan Dong Kexing Bioproducts Co.Ltd(688136)
Chinese abbreviation of the company Shan Dong Kexing Bioproducts Co.Ltd(688136)
The foreign language name of the company is Shandong Kexing bioproducts Co Ltd
The abbreviation of the company’s foreign name is sdkx
Legal representative of the company: Deng Xueqin
The registered address of the company is 2666 Chuangye Road, Bucun street, Zhangqiu District, Jinan City, Shandong Province
On June 26, 2014, it was changed from “tangwangshan Road, Mingshui Development Zone, Zhangqiu City, Shandong Province” to “No. 2666 Chuangye Road, Mingshui Development Zone, Zhangqiu City, Shandong Province”;
On June 23, 2017, it was changed from “No. 2666, Chuangye Road, Mingshui Development Zone, Zhangqiu City, Shandong Province” to “No. 2666, Chuangye Road, Mingshui Development Zone, Zhangqiu District, Jinan City, Shandong Province”;
Historical changes of the company’s registered address on August 17, 2017, Changed from “No. 2666, Chuangye Road, Mingshui Development Zone, Zhangqiu District, Jinan City, Shandong Province” to “No. 2666, Chuangye Road, Mingshui Development Zone, Zhangqiu District, Jinan City, Shandong Province (production place: No. 2666, Chuangye Road, Mingshui Development Zone, production place: Chemical Industrial Park, erdiao Town, east of Shengquan East Road)”
On February 25, 2022, it was changed from “No. 2666, Chuangye Road, Mingshui Development Zone, Zhangqiu District, Jinan City, Shandong Province (production place: No. 2666, Chuangye Road, Mingshui Development Zone, production place: Chemical Industrial Park, erdiao Town, east of Shengquan East Road)” to “No. 2666, Chuangye Road, Bucun street, Zhangqiu District, Jinan City, Shandong Province”.
The company’s office address is 2666 Chuangye Road, Bucun street, Zhangqiu District, Jinan City, Shandong Province
Chuangyi technology building, the intersection of Gaoxin Zhongyi road and Keji Zhongyi Road, Nanshan District, Shenzhen
The postal code of the company’s office address is 250200
five hundred and eighteen thousand
Company website: www.kexing.com com.
E-mail [email protected].
2、 Contact person and contact information
Secretary of the board of directors (domestic representative of information disclosure) securities affairs representative
Name: Wang Xiaoqin, Yan longying
Contact address: 19 / F, building B, Chuangyi science and technology building, intersection of high tech middle 1st Road and science and technology middle 1st Road, Nanshan District, Shenzhen
Tel: 075586967773075586967773
Fax: 075586967891
E-mail [email protected]. [email protected].
3、 Information disclosure and preparation location
The media name and website of the annual report disclosed by the company include China Securities News, Shanghai Securities News, securities times and Securities Daily
Website of the stock exchange where the company discloses the annual report www.sse com. cn.
The company’s annual report is prepared at the office of the board of directors of the company
4、 Company stock / depositary receipts profile (I) company stock profile √ applicable □ not applicable
